ArticleBMC veterinary research2025
Involvement of central opioid and melanocortin receptors in spexin-induced hypophagia following intracerebroventricular injection in neonatal broiler chicks.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modulation of feeding behavior by central adropin injection in neonatal broiler chicks: evidence for NPY and melanocortin signaling pathways involvement.BMC veterinary research · 2026Article
- Short-chain fatty acids differentially regulate feed intake and hypothalamic appetite-related genes in layer-type chicks.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNumerous physiological properties have been documented in the literature pertaining to spexin, such as its role in appetite regulation. Therefore, the present research aimed to assess the impacts of centrally administering spexin and its interaction with opioid and melanocortin receptors on feeding behavior in neonatal broiler chicks. In experiment 1, the chickens were administered intracerebroventricular (ICV) injection of saline and spexin at varying doses of 5, 7.5 and 10 nmol. During the experiment 2, the broilers were subjected to an ICV injection containing saline, β-FNA (µ-opioid receptor antagonist, 5 µg), spexin (10 nmol), and a mixture of β-FNA plus spexin. Experiments 3 to 6 bore resemblance to experiment 2, with the exception that NTI (δ-opioid receptor antagonist, 5 µg), nor-BNI (κ-opioid receptor antagonist, 5 µg), SHU9119 (MC3/MC4 receptor antagonist, 0.5 nmol) and MCL0020 (MC4 receptor antagonist, 0.5 nmol) were administered instead of β-FNA. Then, the birds were promptly placed back into their individual cages and cumulative food intake was assessed at intervals of 30, 60, and 120 min postinjection.
resultsSpexin demonstrated a significant and dose-dependent decrease in food intake when compared to the control group (P < 0.05). Co-injection of β-FNA + spexin diminished spexin-induced hypophagia (P < 0.05) whereas concurrent administration of NTI and nor-BNI with spexin led to an amplification of the decrease in food consumption induced by spexin (P < 0.05). Additionally, anorexigenic impact of spexin was reversed by combined injection of SHU9119 and MCL0020 with spexin (P < 0.05).
conclusionThese observations suggest that both opioid and melanocortin receptors play crucial role in spexin-induced hypophagia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.